GE HealthCare Technologies (GEHC Quick QuoteGEHC - Free Report) reported $4.84 billion in revenue for the quarter ended June 2024, representing a year-over-year increase of 0.5%. EPS of $1.00 for the same period compares to $0.92 a year ago.

The reported revenue represents a surprise of -1.03% over the Zacks Consensus Estimate of $4.89 billion. With the consensus EPS estimate being $0.98, the EPS surprise was +2.04%.

While investors closely watch year-over-year changes in headline numbers -- revenue and earnings -- and how they compare to Wall Street expectations to determine their next course of action, some key metrics always provide a better insight into a company's underlying performance.

As these metrics influence top- and bottom-line performance, comparing them to the year-ago numbers and what analysts estimated helps investors project a stock's price performance more accurately.

Here is how GE HealthCare performed in the just reported quarter in terms of the metrics most widely monitored and projected by Wall Street analysts:

• Revenues- Imaging

  : $2.60 billion compared to the $2.66 billion average estimate based on three analysts.

• Revenues- Ultrasound

  : $823 million versus $842.60 million estimated by three analysts on average.

• Revenues- Other

  : $9 million compared to the $19.63 million average estimate based on three analysts.

• Revenues- PDx

  : $639 million compared to the $603.42 million average estimate based on three analysts.

• Revenues- PCS

  : $772 million versus the three-analyst average estimate of $764.73 million.

View all Key Company Metrics for GE HealthCare here>>>

Shares of GE HealthCare have returned +8.3% over the past month versus the Zacks S&P 500 composite's -0.4% change. The stock currently has a Zacks Rank #3 (Hold), indicating that it could perform in line with the broader market in the near term.